Who are Hypertonic Saline 7%'s main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): AS 50% eye drops 8*1, Mannitol Inhalation Kit, Saline Solution, Hypertonic, Mannitol Inhalant Product, NaCl 7.5%, Mannitol (Aridol).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/hypertonic-saline-7.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

Hypertonic Saline 7% — Competitive Intelligence Brief

Hypertonic Saline 7% (Hypertonic Saline 7%) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Osmotic agent. Area: Neurology / Critical Care.

marketed Osmotic agent Neurology / Critical Care Small molecule Live · refreshed every 30 min

Target snapshot

Hypertonic Saline 7% (Hypertonic Saline 7%) — The Hospital for Sick Children. Hypertonic saline creates an osmotic gradient that draws fluid from intracellular and interstitial spaces into the vascular compartment, reducing intracranial pressure and cellular edema.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
Hypertonic Saline 7% TARGET	Hypertonic Saline 7%	The Hospital for Sick Children	marketed	Osmotic agent
*AS 50% eye drops 81**	AS 50% eye drops 8*1	Seref istek	marketed	Osmotic agent
Mannitol Inhalation Kit	Mannitol Inhalation Kit	Dr. Diane Lougheed	marketed	Osmotic agent / Airway clearance therapy
Saline Solution, Hypertonic	Saline Solution, Hypertonic	Medical University of Silesia	marketed	Osmotic agent
Mannitol Inhalant Product	Mannitol Inhalant Product	University of North Carolina, Chapel Hill	marketed	Osmotic agent / Airway clearance agent
NaCl 7.5%	NaCl 7.5%	Aristotle University Of Thessaloniki	marketed	Osmotic agent / Electrolyte solution
Mannitol (Aridol)	Mannitol (Aridol)	University of Saskatchewan	marketed	Osmotic agent / Diagnostic bronchial challenge agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Osmotic agent class)

Arbor Pharmaceuticals, Inc. · 1 drug in this class
Innogene Kalbiotech Pte. Ltd · 1 drug in this class
Medical University of Silesia · 1 drug in this class
Seref istek · 1 drug in this class
The Hospital for Sick Children · 1 drug in this class
Université de Sherbrooke · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Hypertonic Saline 7% — Competitive Intelligence Brief. https://druglandscape.com/ci/hypertonic-saline-7. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab